Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 2 AGIO Agios Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 AGIO Agios Pharmaceuticals, Inc. (AGIO) Q1 2024 Earnings Call Transcript
May 2 ALNY Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2024 Earnings Call Transcript
May 2 ALKS Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
May 2 ALNY Alnylam Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 ARCT Gritstone bio Inc. (GRTS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
May 2 ALNY Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
May 2 ALNY Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
May 2 AGIO Agios Pharmaceuticals Reports Q1 2024 Earnings: Narrower Loss than Expected with Strong Revenue ...
May 2 AGIO Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
May 2 ALNY Alnylam Pharmaceuticals Non-GAAP EPS of -$0.16 beats by $0.32, revenue of $494.3M beats by $67.44M
May 2 ALNY Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
May 2 AGIO Agios Pharmaceuticals GAAP EPS of -$1.45 beats by $0.20, revenue of $8.19M misses by $0.18M
May 2 ALKS Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
May 2 AGIO Agios Reports Business Highlights and First Quarter 2024 Financial Results
May 1 AGIO Agios Pharmaceuticals Q1 2024 Earnings Preview
May 1 ALNY Alnylam Pharmaceuticals Q1 2024 Earnings Preview
May 1 ALKS Alkermes plc (ALKS) Q1 2024 Earnings Call Transcript
May 1 ALKS Alkermes plc 2024 Q1 - Results - Earnings Call Presentation
May 1 ARCT Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags